Eosinophil peroxidase promotes the switch from pro-inflammatory to pro-resolving macrophages and ameliorates LPS-induced lung inflammation.

Abstract Eosinophils are traditionally recognized as immune effector cells in allergic and parasitic diseases, but their emerging roles in tissue homeostasis make them particularly intriguing cells to study in the context of tissue inflammation. Our study uncovers a previously unrecognized crosstalk between eosinophils and macrophages that is essential for resolving inflammation. Single-cell RNA sequencing shows that eosinophil deficiency leads to a global hyperactivated monocyte/macrophage lineage, underscoring the baseline regulatory role of eosinophils in myeloid homeostasis. We identify eosinophil peroxidase (EPX), a protein long associated with cytotoxicity and tissue damage, as the key mediator of macrophage regulation by eosinophils. We demonstrate that EPX orchestrates a time-dependent reprogramming of macrophages, driving a transition from a pro-inflammatory to a pro-resolving phenotype. This shift is characterized by metabolic flexibility, transient mitochondrial activation followed by redox homeostasis, and enhanced efferocytosis. This EPX-driven macrophage shift dependents on CD11b signaling. Notably, systemic or intranasal EPX administration attenuates LPS-induced acute lung injury, preserving alveolar macrophages and promoting a regulatory interstitial macrophage signature. Our findings reveal a previously unrecognized EPX-CD11b-metabolic axis that drives macrophage-mediated resolution of inflammation.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11481985/v1
Primary Topic
Asthma and respiratory diseases
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Eosinophil peroxidase promotes the switch from pro-inflammatory to pro-resolving macrophages and ameliorates LPS-induced lung inflammation.

René Pfeifle, Gerhard Krönke, Aline Bözec, Georg Andreas Schett et al.
Research Square
Asthma and respiratory diseases
preprint

Eosinophil peroxidase promotes the switch from pro-inflammatory to pro-resolving macrophages and ameliorates LPS-induced lung inflammation.

René Pfeifle, Gerhard Krönke, Aline Bözec, Georg Andreas Schett, Yussuf Hajjaj, Lady Tatiana Albarracin Melo, Jean-Philippe Auger, Darja Andreev, Pauline Porschitz, Md Adnan Karim, Mohammed Safhi, Ashwin Rajaseker
preprint en

Abstract

Abstract Eosinophils are traditionally recognized as immune effector cells in allergic and parasitic diseases, but their emerging roles in tissue homeostasis make them particularly intriguing cells to study in the context of tissue inflammation. Our study uncovers a previously unrecognized crosstalk between eosinophils and macrophages that is essential for resolving inflammation. Single-cell RNA sequencing shows that eosinophil deficiency leads to a global hyperactivated monocyte/macrophage lineage, underscoring the baseline regulatory role of eosinophils in myeloid homeostasis. We identify eosinophil peroxidase (EPX), a protein long associated with cytotoxicity and tissue damage, as the key mediator of macrophage regulation by eosinophils. We demonstrate that EPX orchestrates a time-dependent reprogramming of macrophages, driving a transition from a pro-inflammatory to a pro-resolving phenotype. This shift is characterized by metabolic flexibility, transient mitochondrial activation followed by redox homeostasis, and enhanced efferocytosis. This EPX-driven macrophage shift dependents on CD11b signaling. Notably, systemic or intranasal EPX administration attenuates LPS-induced acute lung injury, preserving alveolar macrophages and promoting a regulatory interstitial macrophage signature. Our findings reveal a previously unrecognized EPX-CD11b-metabolic axis that drives macrophage-mediated resolution of inflammation.

Research Square
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Universitätsklinikum Erlangen (DE), Technische Universität Dresden (DE), Charité - Universitätsmedizin Berlin (DE)
Deutsche Forschungsgemeinschaft, Boehringer Ingelheim Stiftung, Leibniz-Gemeinschaft
Good health and well-being
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon